Literature DB >> 12482877

Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure.

Yu Sun1, Mingming Hao, Yi Luo, Chien-ping Liang, David L Silver, Celina Cheng, Frederick R Maxfield, Alan R Tall.   

Abstract

Liver X receptor/retinoid X receptor (LXR/RXR) transcription factors have been found to induce a number of genes involved in the regulation of cellular cholesterol efflux, including the ATP-binding cassette transporter A1 (ABCA1), which mediates the active efflux of cellular cholesterol and phospholipids to extracellular acceptors, such as apolipoprotein A-I (apoA-I). In a screen for macrophage LXR/RXR target genes, we identified stearoyl-CoA desaturases 1 and 2 (Scd1 and Scd2), and subsequently tested the hypothesis that SCD activity might modulate cellular cholesterol efflux. In HEK 293 cells co-transfection of ABCA1 with either SCD1 or SCD2 inhibited ABCA1-mediated cholesterol efflux but not phospholipid efflux. In Chinese hamster ovary (CHO) cells with moderate stable overexpression of SCD1, cholesterol efflux to apoA-I was inhibited by 73%, whereas phospholipid efflux and ABCA1 protein levels were unchanged. In contrast, cholesterol efflux to HDL(2), which is not dependent on ABCA1, was increased 2-fold in CHO-SCD1 cells. The effect of SCD on cholesterol efflux to apoA-I was independent of acyl-CoA:cholesterol acyltransferase (ACAT) activity. SCD activity led to an increased content of plasma membrane monounsaturated fatty acids (18:1) at the expense of saturated fatty acids (18:0). As shown by confocal microscopy, SCD overexpression led to a decrease of Triton X-100-resistant domains in the plasma membrane, indicating a decrease in membrane-ordered regions. The data suggest that SCD changes membrane organization and depletes a specific pool of membrane cholesterol supporting ABCA1-mediated efflux, whereas increasing availability of cholesterol for passive efflux by HDL(2). ABCA1-mediated cholesterol and phospholipid efflux may be uncoupled in pathological states associated with high SCD activity, as in hyperinsulinemic obese mice, or in animals treated with LXR activators.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482877     DOI: 10.1074/jbc.M208687200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

3.  Membrane organization and regulation of cellular cholesterol homeostasis.

Authors:  María S Jaureguiberry; M Alejandra Tricerri; Susana A Sanchez; Horacio A Garda; Gabriela S Finarelli; Marina C Gonzalez; Omar J Rimoldi
Journal:  J Membr Biol       Date:  2010-03-25       Impact factor: 1.843

4.  Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells.

Authors:  Shaobo Zhang; Yanzhu Yang; Yuguang Shi
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 5.  Lipid packing determines protein-membrane interactions: challenges for apolipoprotein A-I and high density lipoproteins.

Authors:  Susana A Sánchez; M Alejandra Tricerri; Giulia Ossato; Enrico Gratton
Journal:  Biochim Biophys Acta       Date:  2010-03-27

Review 6.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport.

Authors:  George H Rothblat; Michael C Phillips
Journal:  Curr Opin Lipidol       Date:  2010-06       Impact factor: 4.776

7.  ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Authors:  Kai Yin; Duan-fang Liao; Chao-ke Tang
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

8.  Investigation of N-aryl-3-alkylidenepyrrolinones as potential Niemann-Pick type C disease therapeutics.

Authors:  Casey C Cosner; John T Markiewicz; Pauline Bourbon; Christopher J Mariani; Olaf Wiest; Madalina Rujoi; Anton I Rosenbaum; Amy Y Huang; Frederick R Maxfield; Paul Helquist
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

9.  Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.

Authors:  J Mark Brown; Soonkyu Chung; Janet K Sawyer; Chiara Degirolamo; Heather M Alger; Tam M Nguyen; Xuewei Zhu; My-Ngan Duong; Amanda L Brown; Caleb Lord; Ramesh Shah; Matthew A Davis; Kathryn Kelley; Martha D Wilson; Jennifer Madenspacher; Michael B Fessler; John S Parks; Lawrence L Rudel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

10.  Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway.

Authors:  Shi-Hao Tan; Guanghou Shui; Jing Zhou; Yin Shi; Jingxiang Huang; Dajing Xia; Markus R Wenk; Han-Ming Shen
Journal:  Autophagy       Date:  2013-11-26       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.